FluoroPharma Medical, Inc. (FPMI)

[Rhodey Red]

.655 on strong volume into lunch break!!! Such a strong move from recent lows and well over 30% up from 52 week lows. Really setting up well for a breakout on BFPET P2 Data and updates for advancements into P3 trials for both CardioPET and BFPET (if data is as positive as I expect)!!! These trials for our imaging agent compounds are quite short in duration which is fantastic for us. Having 2 compounds potentially in P3 trials simultaneously is AWESOME!!! Really think that the older SA article I posted earlier presents a clear and plausible scenario of how well Flourophrma is positioned as a leader in the midst of the market transition from SPECT to PET technology.
Again, for me, this is a huge long term play with minimal downside risk (always set your stops for your risk comfort level) and huge upside potential within the Billion Dollar Imaging Space.

Have a great day everyone!!!

RR